Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir triple therapy in HCV GT1/HBV co-infected patients
NCT02060058Phase 3Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Nov 2013
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of boceprevir in hepatitis C virus infection, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Nov 2013; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02060058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060058.